Yes, modulating PKA activity has therapeutic potential. By targeting the cAMP/PKA pathway, researchers aim to develop treatments for conditions where PKA activity is dysregulated. For instance, inhibitors of PKA are being explored for their potential in treating certain cancers where PKA activity is abnormally high.